You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRISPR

Showing 51 - 75 of 99
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in San Francisco, Saint Louis, Camden (EBT-101)

Enrolling by invitation
  • HIV-1-infection
  • EBT-101
  • San Francisco, California
  • +2 more
Oct 17, 2022

Duchenne Muscular Dystrophy Trial in Worcester (CRD-TMH-001)

Enrolling by invitation
  • Duchenne Muscular Dystrophy
  • Worcester, Massachusetts
    UMass Chan Medical School
Aug 22, 2022

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy,

Recruiting
  • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
  • +2 more
  • NTLA-2001
  • Paris, France
  • +3 more
Nov 29, 2022

Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)

Recruiting
  • Non-hodgkin Lymphoma,B Cell
  • Autologous CD19-STAR-T cell
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2022

HIV-1-infection Trial in San Francisco, Saint Louis, Camden (EBT-101)

Recruiting
  • HIV-1-infection
  • EBT-101
  • San Francisco, California
  • +2 more
Mar 24, 2022

ß Thalassemia Major Trial in Shanghai (?-globin reactivated autologous hematopoietic stem cells)

Active, not recruiting
  • β Thalassemia Major
  • γ-globin reactivated autologous hematopoietic stem cells
  • Shanghai, Shanghai, China
    Shanghai Bioray Laboratories Inc.
Oct 9, 2022

Retinitis Pigmentosa Trial (ZVS203e)

Not yet recruiting
  • Retinitis Pigmentosa
  • (no location specified)
Mar 27, 2023

Proof Diagnostics Test System Including Proof Diagnostics Reader

Completed
  • COVID-19
  • Asymptomatic COVID-19
  • Proof Lab Test System
  • Spring Hill, Florida
  • +2 more
Apr 15, 2022

Hereditary Angioedema Trial in Amsterdam, Auckland, Cambridge (Biological NTLA-2002, Normal Saline IV Administration)

Recruiting
  • Hereditary Angioedema
  • Biological NTLA-2002
  • Normal Saline IV Administration
  • Amsterdam, Netherlands
  • +2 more
Jul 18, 2022

Sickle Cell Disease Trial (Exa-cel)

Not yet recruiting
  • Sickle Cell Disease
  • Exa-cel
  • (no location specified)
Jul 14, 2023

Exploiting Epigenome Editing in Kabuki Syndrome:New Route

Completed
  • Kabuki Syndrome 1
  • Intervention on primary cultured cells
  • Montpellier, Herault, France
    Arnaud de villeneuve Hospital
Nov 30, 2020

Methods in People Living With Retroviral Infection in Liberia

Active, not recruiting
  • Tuberculosis
  • HIV
    • Bethesda, Maryland
    • +4 more
    Jan 14, 2023

    Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)

    Recruiting
    • Transfusion Dependent Beta Thalassemia
    • +3 more
    • EDIT-301
    • Oakland, California
    • +3 more
    Jan 3, 2023

    A Long-term Follow-up Study of Patients Who Received VOR33

    Recruiting
    • Leukemia, Myeloid, Acute
    • VOR33
    • La Jolla, California
    • +7 more
    Aug 9, 2022

    Advanced Breast Cancer, Breast Tumor Malignant Female Trial in Guangzhou (AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells)

    Completed
    • Advanced Breast Cancer
    • Breast Neoplasm Malignant Female
    • AJMUC1- PD-1 gene knockout anti-MUC1 CAR-T cells
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Apr 11, 2023

    Leukemia, Myeloid, Acute Trial in Canada, United States (VOR33, Mylotarg)

    Recruiting
    • Leukemia, Myeloid, Acute
    • La Jolla, California
    • +8 more
    Jan 31, 2023

    Pine Trees Health Test System Including Pine Trees Health Reader

    Completed
    • SARS (Severe Acute Respiratory Syndrome)
    • Covid19
    • The Pine Trees Health Test System
    • Spring Hill, Florida
    • +2 more
    Nov 2, 2021

    COVID-19 Trial

    Not yet recruiting
    • COVID-19
      • (no location specified)
      Jan 12, 2022

      Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus

      Not yet recruiting
      • Advanced Gastric Carcinoma
      • PDO group
      • Traditional group
      • Shanghai, Sahnghai, China
        Shanghai Ruijin Hospttal
      Apr 22, 2022

      Atopic Dermatitis, Pruritus, Pruritus Chronic Trial in Minneapolis (Naltrexone, Placebo)

      Not yet recruiting
      • Atopic Dermatitis
      • +3 more
      • Minneapolis, Minnesota
        University of Minnesota
      Feb 25, 2022

      Thalassemia Trial (iHSCs treatment group)

      Unknown status
      • Thalassemia
      • iHSCs treatment group
      • (no location specified)
      Nov 1, 2018

      Assessing Causality of CREBBP and EP300 Variants.

      Recruiting
      • Rubinstein-Taybi Syndrome
      • skin biopsy for the primary fibroblast culture and a 15 ml blood sample (3 unnamed samples of 5ml) in each of the 4 SRT patients included.
      • +4 more
      • Talence, France
        Centre Hospitalier Universitaire de Bordeaux
      Oct 7, 2021

      Solid Tumor, Adult Trial in Beijing (Mesothelin-directed CAR-T cells)

      Unknown status
      • Solid Tumor, Adult
      • Mesothelin-directed CAR-T cells
      • Beijing, Beijing, China
        Chinese PLA General Hospital
      Nov 19, 2018

      Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)

      Recruiting
      • Neurodegenerative Disease, Hereditary
      • +2 more
      • Mutation analysis
      • Buffalo, New York
        UBMD Pediatrics
      Mar 3, 2022

      Non Hodgkin's Lymphoma Trial in China (Chidamide, Fludarabine and cyclophosphamide, Anti-CD19 CAR-T cells)

      Recruiting
      • Non Hodgkin's Lymphoma
      • Beijing, Beijing, China
      • +12 more
      Jun 9, 2022